Do amniotic fluid-derived stem cells differentiate into neurons in vitro?
To the editor: Last year, De Coppi et al. 1 reported that amniotic fluid-derived stem (AFS) cells can yield differentiated cells that express lineagespecific markers and acquire characteristic functions in vitro. In particular, in addition to other cell types, they assert that AFS cells can give rise in vitro to neurons. To support this, the authors provide data indicating that AFS cells exposed to a medium that has been previously shown to promote neuronal differentiation express typical neuronal markers. They also show that they can record a bariumsensitive potassium current from these cells and that the cells release glutamate. Given our specific competence and experience, we cannot comment on the characterization of nonneuronal types. We do think, however, that the presented data do not provide compelling evidence that AFS cells can specifically differentiate into neurons.
In [4] [5] [6] [7] . Kir3.2 isoforms are widely distributed in different cell types and are not specific to neurons; in fact, Kir3.2b (GIRK2b) is considered to be ubiquitously expressed and Kir3.2d (GIRK2d) is expressed also in mouse testis [6] [7] [8] .
Fourth, by definition, GIRK channels are inward-rectifier potassium channels activated by G proteins following interaction between specific G proteins and agonists. In the absence of agonist, the background activity of GIRK channels is negligible, as clearly demonstrated by dose-response experiments (e.g., see refs. 9,10). The currents observed in the absence of agonist in Figure 3d of the De Coppi et al. paper suggest that a channel other than GIRK is active in these cells. It is possible that the agonist-independent currents result from activation of IRK (inward-rectifier potassium) channels, which are expressed in many cells types in addition to being expressed in neurons 11 .
Fifth, barium caused partial depression of current in the AFS-derived cells (Fig. 3e of the De Coppi et al. paper). Barium, however, is a nonspecific blocker of different K + channel subtypes, including GIRK, IRK, K2p and some Kv channels 12 . These experiments cannot provide evidence that AFS cells develop into functional and active neurons.
And lastly, Figure 3f of their paper shows glutamate release from the AFS cells following growth in the differentiation medium. Glutamate can be released from astrocytes, osteoblasts, liver cells and neurons, and, as such, glutamate release is not a neuronspecific property [13] [14] [15] .
The main feature that distinguishes neurons from other cell types is their ability to fire tetrodotoxin-sensitive action potentials with a characteristic shape and duration. To support the claim that AFS cells can differentiate into neurons, the authors could have used well-accepted approaches, such as determining whether (i) the cells express voltage-gated Na + channels, (ii) the cells have a resting membrane potential close to values expected for excitable cells and below the voltage for Na + channel steady-state inactivation, (iii) channel activation elicits tetrodotoxin-sensitive Na + current and (iv) the generation of sizeable Na + currents correlates with the capability of the cells to produce action potentials. One more critical parameter for the identification of neurons from undifferentiated stem cells could be the demonstration of synapses by electron microscopy. This is another hard marker of neuron identity not observed in Tuj1 + neuron-like populations obtained from nonneural sources.
De Coppi et al. also present initial studies suggesting that AFS cells directed toward a neural lineage are able to widely engraft into the developing mouse brain (Fig.  4a-f from their paper). To us, the pictures presented only indicate that the authors are able to localize the donor cells within the choroid plexus and in close proximity to the ventricles using an antibody that recognizes the donor human cells. No claims about integration can be raised on the basis of the data presented. In addition, the author made no attempt to show that donor cells develop characteristic neuronal markers or C O R R E S P O N D E N C E morphology. Indeed, considering that donor cells have been exclusively visualized by an antibody against a 65-kDa mitochondrial protein with perinuclear localization, it is difficult to understand the claim that transplanted cells "integrate seamlessly and appear morphologically indistinguishable from surrounding murine cells," which were only labelled by the nuclear stain DAPI (4'-6-diamidino-2-phenylindole).
In conclusion, in our view the article by De Coppi et al. fails to provide any convincing evidence to support the claim that AFS cells are able to generate neurons. Given the medical and ethical impact of such claims, it is important that the contention that AFS cells can generate functional neurons be fully substantiated. 
